According to Mallinckrodt Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 13,200,000. At the end of 2023 the company had 13,200,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 13.2 M | 0% |
2022 | 13.2 M | -84.42% |
2021 | 84.7 M | 0.12% |
2020 | 84.6 M | 0.59% |
2019 | 84.1 M | 0.96% |
2018 | 83.3 M | -9.65% |
2017 | 92.2 M | -12.77% |
2016 | 0.10 B | -8.41% |
2015 | 0.11 B | 0.52% |
2014 | 0.11 B | 98.62% |
2013 | 57.8 M | -31.84% |
2012 | 84.8 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 18,136.36% | ๐บ๐ธ USA |
General Electric GE | 1,091,000,000 | 8,165.15% | ๐บ๐ธ USA |
Zogenix ZGNX | 55,340,700 | 319.25% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 8,392.42% | ๐ฎ๐ฑ Israel |